SEO URLwww.firestrike.ai/deals/revolution-medicines-merck-acquisition-2026-3
acquisitionAnnounced · Jan 25, 2026BiotechnologySource · CredibleArticle · Factual
Merck acquires Revolution Medicines
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$30B
Target
Revolution Medicines
Acquirer
Merck
Full Acquisition
Status
Ended
Merck agreed to acquire Revolution Medicines. Reported deal value: $30B. Status: Ended. Sector: Biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-25. Figures and status may change as filings and press coverage update.
Merck & Co Inc. is no longer in discussions to acquire biotech company Revolution Medicines , according to a report from the Wall Street Journal citing people familiar with the matter
Deal timeline
Announced
Jan 25, 2026 · nasdaq.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $30B. Figures and status may change as sources update.
Sources: nasdaq.com · Primary article · FireStrike proprietary index